The aforementioned facts are the main reason that oxytocin was studied in the drug component of the active management of uterotonic administration in this integrative
review. Taking into account the three Cochrane reviews
included in this study, oxytocin is the drug of choice in the
TSL for preventing PPH (McDonald et al. 2009, Cotter
et al. 2010, Soltani et al. 2010).